Bioventus to acquire Bioness for up to $110m.

Bioventus, a company specialized in innovations for active healing, agreed to acquire Bioness, a provider of neuromodulation and rehabilitation medical devices, for up to $110m. "Bioness has developed groundbreaking and best in class technologies, and we are excited about the opportunity for Bioventus to further Bioness’ vision of improving the lives of patients," Ken Reali, Bioventus CEO.